Clinical correlates of very high brain natriuretic peptide levels in hospitalized patients

American Heart Hospital Journal

Volumn 6, Issue 1, 2008, Pages 37-41

  Cuculi, Florim ^a   Walz, Brigitte ^a   Zuber, Michel ^a   Roos, Markus ^a   Erne, Paul ^a  

^a Kantonsspital Luzern ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SIZE; HOSPITAL PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; FORWARD HEART FAILURE; KIDNEY FAILURE; MIDDLE AGED; SWITZERLAND;

AGED; AGED, 80 AND OVER; CARDIAC OUTPUT, LOW; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; INPATIENTS; KIDNEY FAILURE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; SWITZERLAND;

EID: 41249096544     PISSN: 15419215     EISSN: 17517168     Source Type: Journal    
DOI: 10.1111/j.1751-7168.2008.07546.x     Document Type: Article

References (27)

1. Goetze JP, Friis-Hansen L, Rehfeld JF, et al. Atrial secretion of B-type natriuretic peptide. Eur Heart J. 2006;27:1648-1650.
2. de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362(9380):316-322.
3. Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand. 2001;171(4):395-403.
4. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167.
5. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106(4):416-422.
6. Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (ValHeFT). Circulation. 2003;107(9):1278-1283.
7. Rienstra M, Van Gelder IC, Van den Berg MP, et al. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace. 2006;8(7):482-487.
8. Gardner RS, Ozalp F, Murday AJ, et al. N-terminal probrain natriuretic peptide: A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24(19):1735-1743.
9. Sakurai S, Adachi H, Hasegawa A, et al. Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction. Heart. 2003;89(6):661-662.
10. Miller WL, Burnett JC Jr, Hartman KA, et al. Lower rather than higher levels of B-type natriuretic peptides (NT-proBNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide. Am J Cardiol. 2005;96(6):837-841.
11. Chung T, Sindone A, Foo F, et al. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department. Am Heart J. 2006;152(5):949-955.
12. McDonagh TA, Holmer S, Raymond I, et al. NT-proBNP and the diagnosis of heart failure: A pooled analysis of three European epidemiological studies. Eur J Heart Fail. 2004;6(3):269-273.
13. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147.
14. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-470.
15. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440-1463.
16. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(11):1115-1140.
17. Devereux RB, Casale PN, Hammond IW, et al. Echocardiographic detection of pressure-overload left ventricular hypertrophy: Effect of criteria and patient population. J Clin Hypertens. 1987;3(1):66-78.
18. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J. 1998;19(7):990-1003.
19. McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365(9474):1877-1889.
20. Wallen T, Landahl S, Hedner T, et al. Brain natriuretic peptide in an elderly population. J Intern Med. 1997;242(4):307-311.
21. Hogenhuis J, Voors AA, Jaarsma T, et al. Influence of age on natriuretic peptides in patients with chronic heart failure: A comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7(1):81-86.
22. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med. 2005;53(7):366-370.
23. O'Donoghue M, Chen A, Baggish AL, et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail. 2005;11(suppl 5):S9-S14.
24. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141(3):367-374.
25. Dokainish H, Zoghbi WA, Lakkis NM, et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. Am J Cardiol. 2004;93(9):1130-1135.
26. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures: A comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters. Circulation. 2004;109(20):2432-2439.
27. Hogenhuis J, Jaarsma T, Voors AA, et al. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients. Int J Cardiol. 2006;108(1):63-67.